SOMATOSTATIN RECEPTORS AS POTENTIALTHERAPEUTIC TARGETS IN THE TREATMENT OF ADVANCED ADRENOCORTICAL CANCER. A CASE REPORT

SOMATOSTATIN RECEPTORS AS POTENTIALTHERAPEUTIC TARGETS IN THE TREATMENT OF ADVANCED ADRENOCORTICAL CANCER. A CASE REPORT

Background. Adrenocortical cancer (ACC) is a rare malignancy of the adrenal cortex. Therapeutic options for advanced ACC are limited. It is necessary to study new and more effective drug combinations and tumor biological targets. The purpose of the study was to determine the expression of somatostat...

Full description

Bibliographic Details
Main Authors:	A. A. Kolomeytseva, V. V. Delektorskaya, N. F. Orel, G. S. Emelianova, V. Y. Bokhian, A. A. Fedenko
Format:	Article
Language:	Russian
Published:	Russian Academy of Sciences, Tomsk National Research Medical Center 2018-05-01
Series:	Сибирский онкологический журнал
Subjects:	рецепторы соматостатина sstr2a sstr5 акр аналоги соматостатина
Online Access:	https://www.siboncoj.ru/jour/article/view/723

Similar Items

Octreotide in the treatment of neuroendocrine carcinomas: Is the success achieved?
by: L. Yu. Morgunov
Published: (2015-06-01)

THE USAGE OF "OCTREOTIDE-DEPOT" FOR THE PREVENTION OF POSTOPERATIVE PANCREATITIS AFTER EXTENDED SURGERY OF MALIGNANT TUMORS OF THE STOMACH, ESOPHAGUS AND THE CARDIA
by: V. M. Khomyakov, et al.
Published: (2016-01-01)

Neuroendocrine Tumours: a Literature Review
by: K. V. Menshikov, et al.
Published: (2021-05-01)

THERAPY WITH SOMATOSTATIN ANALOGUES IN PATIENTS WITH CASTRATION-REFRACTORY PROSTATE CANCER
by: K. Y. Kanukoev, et al.
Published: (2015-04-01)

Somatostatin Serves a Modulatory Role in the Mouse Olfactory Bulb: Neuroanatomical and Behavioral Evidence
by: Sonia Nocera, et al.
Published: (2019-04-01)

Prevalence of acromegaly and clinical guidelines
by: V. S. Pronin, et al.
Published: (2014-12-01)

Comprehensive Assessment of Somatostatin Receptors in Various Neoplasms: A Systematic Review
by: Shista Priyadarshini, et al.
Published: (2022-07-01)

Alpha-peptide receptor radionuclide therapy using actinium-225 labeled somatostatin receptor agonists and antagonists
by: Mengqi Shi, et al.
Published: (2022-12-01)

Selective somatostatin receptor 5 inhibition improves hepatic insulin sensitivity
by: Yumiko Okano Tamura, et al.
Published: (2023-02-01)

Somatostatin Receptors in Human Meningiomas—Clinicopathological Aspects
by: Sofie Eline Tollefsen, et al.
Published: (2021-11-01)

A Clinicopathological Analysis of Asian Patients with Adrenocortical Carcinoma: A Single-Center Experience
by: Wen-Hsuan Tsai, et al.
Published: (2023-04-01)

Radiomics and Artificial Intelligence in Radiotheranostics: A Review of Applications for Radioligands Targeting Somatostatin Receptors and Prostate-Specific Membrane Antigens
by: Elmira Yazdani, et al.
Published: (2024-01-01)

Aberrant Methylation of Somatostatin Receptor 2 Gene Is Initiated in Aged Gastric Mucosa Infected with <i>Helicobacter pylori</i> and Consequential Gene Silencing Is Associated with Establishment of Inflammatory Microenvironment In Vitro Study
by: Hee-Jin Kim, et al.
Published: (2022-12-01)

Immunological role and prognostic value of somatostatin receptor family members in colon adenocarcinoma
by: Xiaoqian Yu, et al.
Published: (2023-10-01)

In-Vivo Somatostatin-Receptor Expression in Small Cell Lung Cancer as a Prognostic Image Biomarker and Therapeutic Target
by: Feyza Şen, et al.
Published: (2023-07-01)

Computational Study of Nocardiotide-A Analogues in the Development of Technetium-99m Radiopeptides for Cancer Imaging for Targeting Somatostatin Receptor 2
by: Rizky Juwita Sugiharti, et al.
Published: (2023-10-01)

Somatostatin Receptor Targeted PET-CT and Its Role in the Management and Theranostics of Gastroenteropancreatic Neuroendocrine Neoplasms
by: Aadil Adnan, et al.
Published: (2023-06-01)

Human Somatostatin SST<sub>4</sub> Receptor Transgenic Mice: Construction and Brain Expression Pattern Characterization
by: Balázs Nemes, et al.
Published: (2021-04-01)

Identification of <i>Somatostatin Receptor Subtype 1 (SSTR1)</i> Gene Polymorphism and Their Association with Growth Traits in Hulun Buir Sheep
by: Xue Li, et al.
Published: (2021-12-01)

SSTR2 Mediates the Inhibitory Effect of SST/CST on Lipolysis in Chicken Adipose Tissue
by: Xiao Zhang, et al.
Published: (2024-03-01)

The Role of Receptor–Ligand Interaction in Somatostatin Signaling Pathways: Implications for Neuroendocrine Tumors
by: Agnieszka Milewska-Kranc, et al.
Published: (2023-12-01)

Construction of three strains of recombinant oncolytic vaccinia virus and their anti-tumor activity
by: LI Dan-yang, FANG Jing-jing, TANG Hui
Published: (2020-04-01)

Insights into the subgenera <i>Chrysolina</i> s. str. and <i>Rhyssoloma</i> Woll. of <i>Chrysolina</i> Mots. (Coleoptera: Chrysomelidae: Chrysomelinae)
by: Eduard Petitpierre
Published: (2023-12-01)

Imaging Inflammation with Positron Emission Tomography
by: Janette Iking, et al.
Published: (2021-02-01)

Systematic of genera Pulicaria Gaertn. and Platycheteae Boiss. from tribe Inuleae s.str (Asteraceae) in Iran
by: Peyman Zarin, et al.
Published: (2010-04-01)

Novel Discovery of the Somatostatin Receptor (SSTR2) in Pleomorphic Adenomas via Immunohistochemical Analysis of Tumors of the Salivary Glands
by: Felix Johnson, et al.
Published: (2023-08-01)

Role of Combined <sup>68</sup>Ga DOTA-Peptides and <sup>18</sup>F FDG PET/CT in the Evaluation of Gastroenteropancreatic Neuroendocrine Neoplasms
by: Chalermrat Kaewput, et al.
Published: (2022-01-01)

Prevalence and significance of incidental findings on 68 Ga-DOTA-conjugated somatostatin receptor-targeting peptide PET/CT: a systematic review of the literature
by: Morten Bentestuen, et al.
Published: (2022-09-01)

The Current Role of Peptide Receptor Radionuclide Therapy in Meningiomas
by: Christina-Katharina Fodi, et al.
Published: (2022-04-01)

Promoter Specific Methylation of SSTR4 is Associated With Alcohol Dependence in Han Chinese Males
by: Rongrong Zhao, et al.
Published: (2022-06-01)

Resistance to Somatostatin Analogs in Italian Acromegaly Patients: The MISS Study
by: Alessandro Maria Berton, et al.
Published: (2022-12-01)

Case Report: Octreotide plus CVD chemotherapy for the treatment of multiple metastatic paragangliomas after double resection for functional bladder paraganglioma and urothelial papilloma
by: Zilong Wang, et al.
Published: (2023-01-01)

Somatostatin-SSTR3-GSK3 modulates human T-cell responses by inhibiting OXPHOS
by: Bo Zhang, et al.
Published: (2024-02-01)

Chemotherapy-Induced Upregulation of Somatostatin Receptor-2 Increases the Uptake and Efficacy of <sup>177</sup>Lu-DOTA-Octreotate in Neuroendocrine Tumor Cells
by: Rashmi G. Shah, et al.
Published: (2021-01-01)

Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [<sup>153</sup>Sm]Sm-DOTA-TATE
by: Koen Vermeulen, et al.
Published: (2022-11-01)

First preclinical evaluation of [225Ac]Ac-DOTA-JR11 and comparison with [177Lu]Lu-DOTA-JR11, alpha versus beta radionuclide therapy of NETs
by: Maryana Handula, et al.
Published: (2023-06-01)

Efficacy of pasireotide LAR for acromegaly: a prolonged real-world monocentric study
by: Vittoria Favero, et al.
Published: (2024-02-01)

Low-dose targeted radionuclide therapy synergizes with CAR T cells and enhances tumor response
by: Yanping Yang, et al.
Published: (2024-03-01)

SSTR2 in Nasopharyngeal Carcinoma: Relationship with Latent EBV Infection and Potential as a Therapeutic Target
by: Oscar Emanuel, et al.
Published: (2021-09-01)

Preparation and preliminary biological evaluation of Gluc-Lys([Al18F]NOTA)-KE108
by: GAO Fei, et al.
Published: (2021-08-01)